Serum 99th centile values for two heart-type fatty acid binding protein assays

D P Bathia1, D R Carless, K Viswanathan

  • 1Department of Clinical Biochemistry, Leeds General Infirmary, UK.

Insights

Heart-type fatty acid binding protein (H-FABP) levels increase with age and renal dysfunction. Defined 99th centile values for H-FABP assays aid in risk stratification for acute coronary syndrome (ACS) patients.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Clinical Chemistry

Background:

  • Heart-type fatty acid binding protein (H-FABP) is a prognostic marker for acute coronary syndrome (ACS) survival.
  • Previous studies indicated H-FABP's prognostic value, necessitating further investigation into assay-specific centile values and influencing factors.

Purpose of the Study:

  • To define the 99th centile values for H-FABP using two distinct assays.
  • To investigate the relationship between H-FABP levels, age, gender, and renal function.

Main Methods:

  • H-FABP was measured using MARKIT-M (Dainippon) and Evidence Investigator (Randox) assays on routine outpatient samples.
  • Subjects with Siemens Ultra-TnI <0.045 microg/L were included, with subgroup analysis based on estimated glomerular filtration rate (eGFR).

Main Results:

  • The 99th centile values for H-FABP varied between assays and genders (e.g., Evidence Investigator: 5.3-5.8 microg/L; MARKIT-M: 8.3-9.1 microg/L for normal renal function).
  • H-FABP levels increased with age and were significantly higher in subjects with impaired renal function (eGFR <60 mL/min) compared to those with normal function.
  • No significant gender difference in H-FABP levels was observed for either assay.

Conclusions:

  • Established 99th centile values for H-FABP provide a reference for risk stratification in ACS patients.
  • H-FABP levels are influenced by age and renal function, with increased levels observed in cases of renal dysfunction.
  • The study did not confirm a previously reported gender difference in H-FABP levels.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...